Health Care: Drugs

AMAG Pharmaceuticals Inc (AMAG: NASDAQ)

$23.92 n/a | n/a%
06/30/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 418.28M 124.38M 80.86M 85.38M
Cost of Sales 5.87M 4.37M 6.12M 8.33M
Gross Operating Profit 412.41M 120.01M 74.74M 77.05M
Selling, General, and Administrative Expenses 160.31M 72.25M 59.95M 53.07M
Research & Development 42.88M 24.16M 20.56M 33.30M
Operating Income before D & A (EBITDA) 209.22M 23.60M -5.77M -9.32M
Depreciation & Amortization 82.63M 15.93M 5.84M 5.89M
Interest Income 1.51M 975.00K 1.05M 1.29M
Other Income - Net -19.64M -9.26M 964.00K -1.47M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 93.09M -2.65M -9.60M -17.60M
Interest Expense 53.25M 14.70M 0.00 0.00
Pre-Tax Income 39.84M -17.34M -9.60M -17.60M
Income Taxes 7.07M -153.16M 0.00 -854.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 32.78M 135.82M -9.60M -16.75M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 32.78M 135.82M -9.60M -16.75M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 32.78M 135.82M -9.60M -16.75M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
48.15M 137.84M -9.60M -14.54M
Preferred Dividends
Net Income Available To Common 32.78M 135.82M -9.60M -16.75M
Basic EPS from Continuing Ops. 1.04 6.06 -0.44 -0.78
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.04 6.06 -0.44 -0.78
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.04 6.06 -0.44 -0.78
Basic Normalized Net Income/Share 1.53 6.15 -0.44 -0.68
EPS fr Continuing Ops. 0.93 5.38 -0.44 -0.78
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.93 5.38 -0.44 -0.78
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.07 0.00 0.00
EPS, Total 0.93 5.45 -0.44 -0.78
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.36 5.46 -0.44 -0.68
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with AMAG

Latest AMAG Headlines from TheStreet

More Financial News for AMAG

Press Releases for AMAG

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter